Search - tctmd.com

Displaying 161 - 180 of 1032

Sort: Relevancy | Date

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

Podcast TCTMD Talking Points

BIONYX: A Thin Composite-Wire Strut, Durable Polymer-Based DES Compared With an Ultrathin-Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

February 20, 2019

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

News Opinion Off Script TCT 2018

Off Script: Phantom Hearts and the Elusive Nature of Angina

Kwan S. Lee

October 11, 2018

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT 2018

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Presenter: Felix Mahfoud, Patrick W. Serruys, Pieter C. Smits

September 25, 2018

Presentation TCT Abstracts Posters 2018

Characterization of Long-Term Mechanical Interaction Between a Bioresorbable Scaffold and Coronary Lesion Throughout Two Years of Scaffold Degradation

Presenter: Tanya Qiu

September 25, 2018

Presentation TCT Abstracts Posters 2018

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

Presenter: Omeed Neghabat

September 25, 2018

Presentation TCT Abstracts Posters 2018

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

Presenter: Cigdem Koca Tari

September 25, 2018

Presentation TCT 2018

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Presenter: Felix Mahfoud, Patrick W. Serruys, Gregg W. Stone

September 25, 2018

Presentation TCT 2018

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Ajay J. Kirtane

September 24, 2018

Presentation TCT 2018

Case #4: OCT Findings and Management of a Dislodged Magnesium-Based Bioresorbable Scaffold

Presenter: Joshua P. Loh, João A Silveira, Chee Yang Chin

September 23, 2018

Presentation TCT 2018

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

September 23, 2018

Presentation TCT 2018

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

Presenter: Fernando Alfonso, Juan F. Granada, Runlin Gao

September 23, 2018

Presentation TCT 2018

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

Presenter: Fernando Alfonso, Juan F. Granada, YunDai Chen

September 23, 2018

Presentation TCT 2018

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Fernando Alfonso, Juan F. Granada, David E. Kandzari

September 23, 2018

Presentation TCT 2018

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Presenter: Michael Haude, Robert-Jan van Geuns, Yaling Han

September 23, 2018

Presentation TCT 2018

NEOVAS: Three-Year OCT and FFR Results From a Randomized Trial Evaluating a Polymeric Bioresorbable Scaffold

Presenter: Michael Haude, Robert-Jan van Geuns, Bo Xu

September 23, 2018

Advertisement

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

BIONYX: A Thin Composite-Wire Strut, Durable Polymer-Based DES Compared With an Ultrathin-Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

Off Script: Phantom Hearts and the Elusive Nature of Angina

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Characterization of Long-Term Mechanical Interaction Between a Bioresorbable Scaffold and Coronary Lesion Throughout Two Years of Scaffold Degradation

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

Case #4: OCT Findings and Management of a Dislodged Magnesium-Based Bioresorbable Scaffold

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

NEOVAS: Three-Year OCT and FFR Results From a Randomized Trial Evaluating a Polymeric Bioresorbable Scaffold

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content